Coronary heart illness: weight reduction medicine could scale back the danger

Science has drawn an important link between weight and the risk of premature death, with studies showing that the shape of a body, especially whether it is apple or pear shaped, can significantly affect the risk of death. Visceral fat is associated with a higher risk of death because internal fat deposits wrap around the abdominal organs deep in the body and thus pose a health risk. Researchers have found a common weight loss drug that could protect the heart by reducing dangerous fats in the body.

The clinical study, led by researchers at UT Southwestern Medical Center, found that a commonly prescribed weight loss drug targets fat, which may help maintain heart health.

The study found that in obese adults at high risk for cardiovascular disease, the drug liraglutide combined with lifestyle interventions significantly reduced the risk of cardiovascular complications.

The researchers explained this because the drug significantly lowered visceral fat and ectopic fat in the body.

While visceral fat is stored in the abdominal cavity, ectopic fat is stored in tissues that usually contain small amounts of fat, such as the liver, skeletal muscle, heart, and pancreas.

CONTINUE READING: How To Lose Visceral Fat: The Hot Drink That Burns Belly Fat When Eaten Once A Day

In addition, visceral fat secretes chemicals known to cause systemic inflammation, increasing the risk of many health complications.

Weight gain in the mid-body region usually indicates a higher amount of visceral fat, making a larger waist-to-hip ratio a significant risk factor for heart attacks.

Parag Joshi, assistant professor of cardiology and lead author on the study, said, “Our study used the latest imaging technology to assess various components of fat in the body.

“The main finding was a significant decrease in visceral fat in patients without diabetes who were overweight or obese.


“These results show the potential of treatment with liraglutide to significantly reduce the risk of chronic disease in the population.”

For the study, the team gave 185 participants one injection of liraglutide once a day for 40 weeks.

The results, published in the Lancet Diabetes and Endocrinology, showed that the effect of liraglutide on fat reduction was twice as effective in abdominal tissue and six times as effective in the liver.

The researchers also found that the drug reduced fasting blood sugar and inflammation in all participants, the majority of whom had normal blood sugar levels initially.

The study’s results reflect a 2016 analysis that found fewer deaths from cardiovascular causes, non-fatal myocardial infarction, or non-fatal stroke in patients treated with liraglutide.

Joshi added, “Our results help add a possible mechanism for why liraglutide has an advantage on cardiovascular outcomes, while demonstrating its benefit in people without diabetes.

“Excess visceral fat and ectopic fat are central to the development of type 2 diabetes and cardiovascular disease. It remains a challenge to identify those at higher risk in order to offer them treatment in addition to lifestyle changes such as diet and exercise. “

According to Health Harvard, there are the following ways to improve heart health:

Take a 10-Minute Walk: The heart is a muscle, and like any muscle, exercise strengthens it.

Eating fruits or vegetables: Five servings of fruits and vegetables a day seem to lower your risk of heart attack and stroke.

Eat nuts: Nuts are not only high in protein, but also contain substances that are healthy for the heart.

Wash Your Hands Frequently: By keeping your hands clean, you can avoid diseases that can hit the heart hard.

Comments are closed.